Functioning SDHx paragangliomas sometimes release dopamine and/or norepinephrine, originating raised plasma levels of methoxytyramine, contributing to distinguish SDHx patients from those with VHL, RET, or NF1 mutations [49, 94]. This evidence concerns the gene NF1 and paraganglioma.